HK1171682A1 - Therapeutic agent for rhinitis - Google Patents

Therapeutic agent for rhinitis

Info

Publication number
HK1171682A1
HK1171682A1 HK12112567.4A HK12112567A HK1171682A1 HK 1171682 A1 HK1171682 A1 HK 1171682A1 HK 12112567 A HK12112567 A HK 12112567A HK 1171682 A1 HK1171682 A1 HK 1171682A1
Authority
HK
Hong Kong
Prior art keywords
rhinitis
therapeutic agent
therapeutic
agent
Prior art date
Application number
HK12112567.4A
Other languages
English (en)
Chinese (zh)
Inventor
Kyoko Endo
Original Assignee
Kyoko Endo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyoko Endo filed Critical Kyoko Endo
Publication of HK1171682A1 publication Critical patent/HK1171682A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2242—Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
HK12112567.4A 2009-08-27 2012-12-05 Therapeutic agent for rhinitis HK1171682A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009197488 2009-08-27
PCT/JP2010/064644 WO2011024973A1 (ja) 2009-08-27 2010-08-27 鼻炎治療剤

Publications (1)

Publication Number Publication Date
HK1171682A1 true HK1171682A1 (en) 2013-04-05

Family

ID=43628070

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12112567.4A HK1171682A1 (en) 2009-08-27 2012-12-05 Therapeutic agent for rhinitis

Country Status (15)

Country Link
US (4) US20130045921A1 (pt)
EP (1) EP2471546B1 (pt)
JP (1) JP4790096B2 (pt)
KR (2) KR101229546B1 (pt)
CN (1) CN102596216B (pt)
AU (1) AU2010287421B2 (pt)
BR (1) BR112012004058A2 (pt)
CA (1) CA2771215C (pt)
DK (1) DK2471546T3 (pt)
ES (1) ES2556336T3 (pt)
HK (1) HK1171682A1 (pt)
MX (1) MX2012002175A (pt)
NZ (1) NZ598600A (pt)
RU (1) RU2502519C2 (pt)
WO (1) WO2011024973A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101226165B1 (ko) 2009-07-23 2013-01-24 가부시키가이샤 이기스 피부 외용제 조성물
KR101229546B1 (ko) 2009-08-27 2013-02-05 쿄고 엔도 비염 치료제
MX353295B (es) * 2011-01-21 2018-01-08 Endo Kyoko Agente para el tratamiento de la alopecia.
WO2013095759A1 (en) 2011-12-23 2013-06-27 Mayo Foundation For Medical Education And Research Assessing renal structural alterations and outcomes
WO2016194855A1 (ja) * 2015-05-29 2016-12-08 株式会社イギス 環状ペプチド並びに該環状ペプチドを含む医薬、外用剤および化粧料
EP3330280A4 (en) * 2015-07-31 2019-06-12 Igisu Co., Ltd. CYCLIC PEPTIDE CNP AND MEDICINE, PREPARATION FOR EXTERNAL USE AND COSMETIC PRODUCT, CONTAINING ALL OF SAID CYCLIC PEPTIDE
CN107847433B (zh) * 2015-08-04 2021-02-05 风之星医疗有限公司 鼻用组合物
CN105617360B (zh) * 2015-12-04 2018-12-21 中国农业大学 C-型钠肽在制备外用避孕药和精子功能检测试剂中的应用
EP3603652B1 (en) 2017-03-21 2023-12-13 Well Stone Co. Production method of nasal drop composition and its use
US10959992B2 (en) 2019-02-22 2021-03-30 Bridge Pharma Inc. Methods of treatment of asthma and COPD
US20200268734A1 (en) * 2019-02-22 2020-08-27 Bridge Pharma, Inc. Methods of treatment of respiratory disorders
CN112057478A (zh) * 2020-10-16 2020-12-11 常州市艾斯康生物医药有限公司 一种用于舒缓和预防过敏性鼻炎的药物制剂
KR102677730B1 (ko) * 2023-03-27 2024-06-27 나인바이오팜 주식회사 지방 분해 효능을 갖는 펩타이드 및 이의 용도

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114923A (en) 1988-05-31 1992-05-19 California Biotechnology Inc. Recombinant techniques for production of novel natriuretic and vasodilator peptides
CA1339210C (en) * 1988-05-31 1997-08-05 John Lewicki Recombinant techniques for production of novel natriuretic and vasodilator peptides
JP2809533B2 (ja) * 1991-01-31 1998-10-08 壽之 松尾 Ｃｎｐ類似体ペプチド
JPH05207891A (ja) 1991-03-08 1993-08-20 Shionogi & Co Ltd 脳性ナトリウム利尿ペプチドの製造方法
WO1994020534A1 (en) 1993-03-03 1994-09-15 Mayo Foundation For Medical Education And Research Vasonatrin peptide and analogs thereof
US6028055A (en) 1996-10-22 2000-02-22 Genetech, Inc. Receptor selective BNP
US5965533A (en) 1997-05-23 1999-10-12 Baxter International Inc. Atrial natriuretic peptide (ANP) as an additive to peritoneal dialysis solutions
WO2000018422A1 (fr) 1998-09-28 2000-04-06 Santen Pharmaceutical Co., Ltd. Promoteurs de secretion lacrymale ou gouttes ophtalmologiques contenant des peptides natriuretiques comme principes actifs pour traiter la keratoconjonctivite
JP3799465B2 (ja) 1998-09-28 2006-07-19 参天製薬株式会社 ナトリウム利尿ペプチドを有効成分とする涙液分泌促進または角結膜障害治療用点眼剤
US6407211B1 (en) 1999-12-17 2002-06-18 Mayo Foundation For Medical Education And Research Chimeric natriuretic peptides
JP3676707B2 (ja) * 2001-07-18 2005-07-27 三菱電機株式会社 車両用交流発電機の固定子およびその製造方法
US7655772B2 (en) * 2002-09-06 2010-02-02 University Of South Florida Materials and methods for treatment of allergic diseases
US20050271596A1 (en) 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US20070270337A1 (en) 2003-06-13 2007-11-22 Daiichi Asubio Pharma Co., Ltd. Pharmaceutical Compositions for Preventing or Treating Th1-Mediated Immune Diseases
CN101208353B (zh) 2003-06-20 2011-12-14 梅约医学教育与研究基金会 脑利尿钠肽的同种型
EP1730181A2 (en) 2004-01-27 2006-12-13 Compugen USA, Inc. Novel brain natriuretic peptide variants and methods of use thereof
JP2007525213A (ja) 2004-01-27 2007-09-06 コンピュゲン ユーエスエイ，インク． 新規の脳性ナトリウム利尿ペプチドの変異体及びその利用方法
CA2561530C (en) * 2004-03-31 2014-04-22 Kazuwa Nakao Therapeutic or prophylactic agent for arthritis
CN1960757A (zh) 2004-03-31 2007-05-09 中尾一和 身高增加用组合物
CA2576852A1 (en) 2004-08-11 2006-02-23 Alza Corporation Apparatus and method for transdermal delivery of natriuretic peptides
DE102004048576A1 (de) 2004-10-04 2006-04-13 Deutsches Zentrum für Luft- und Raumfahrt e.V. Methode zur Bräunung der Haut
EP1810716A1 (de) 2005-12-23 2007-07-25 Deutsches Zentrum für Luft- und Raumfahrt e.V. Verfahren zur Bräunung der Haut
EP2051585A4 (en) * 2006-04-28 2010-06-02 Univ South Florida MATERIALS AND METHODS OF SUPPRESSING INFLAMMATION THROUGH INHIBITION OF THE VORHOF RECEPTOR FOR NATRIURETIC PEPTIDES
BRPI0716416A2 (pt) 2006-08-08 2016-10-11 Mayo Foundation polipeptídeo substancialmente puro entre 37 e 47 besíduos de aminoácido de comprimento, ácido nucléico isolado, vetor: célula hospedeira e composição farmacêutica
BRPI0716228A2 (pt) 2006-09-08 2013-10-15 Mayo Foundation Polipeptídeos aquaréticos e natriuréticos carecendo de atividade vasodilatadora
JPWO2008032450A1 (ja) 2006-09-15 2010-01-21 国立大学法人京都大学 脂肪肝の予防剤および／または治療剤
JP5010913B2 (ja) 2006-12-31 2012-08-29 寿子 小出 心房利尿ホルモンファミリー分子を活性物質として含有する組織再生製剤また該製剤をもちいる組織再生方法、および心房利尿ホルモンファミリー分子を活性物質として含有する発毛、増毛、育毛剤および皮膚組織修復改善剤また該製剤を用いる発毛、増毛、育毛促進方法および皮膚組織修復改善方法
JP2010168283A (ja) 2007-04-24 2010-08-05 Yamaguchi Univ ナトリウム利尿ペプチドを有効成分とする肝硬変・前癌病変の抑制剤
JP5207316B2 (ja) 2007-05-10 2013-06-12 国立大学法人名古屋大学 腹膜線維化抑制用医薬組成物
WO2009046865A2 (en) 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Cholecystokinin-33 alone or in combination with trap-14 as therapeutic agent
EP2187953A2 (en) * 2007-09-11 2010-05-26 Mondobiotech Laboratories AG Use of a peptide as a therapeutic agent
AU2008326327A1 (en) 2007-11-21 2009-05-28 Biomarin Pharmaceutical Inc. Variants of C-type natriuretic peptide
WO2010048308A2 (en) * 2008-10-24 2010-04-29 Deborah Dickey Natriuretic polypeptides
US8455438B2 (en) * 2008-12-29 2013-06-04 Mayo Foundation For Medical Education And Research Natriuretic polypeptides for reducing or preventing restenosis
DK3175863T3 (da) * 2009-05-20 2022-02-07 Biomarin Pharm Inc Varianter af c-type natriuretisk peptid
KR101229546B1 (ko) 2009-08-27 2013-02-05 쿄고 엔도 비염 치료제

Also Published As

Publication number Publication date
US20180318395A1 (en) 2018-11-08
EP2471546B1 (en) 2015-11-25
AU2010287421B2 (en) 2013-06-13
CN102596216A (zh) 2012-07-18
KR20120060219A (ko) 2012-06-11
JP4790096B2 (ja) 2011-10-12
CA2771215A1 (en) 2011-03-03
EP2471546A4 (en) 2013-02-20
US9358270B2 (en) 2016-06-07
BR112012004058A2 (pt) 2021-08-17
NZ598600A (en) 2014-03-28
KR101229546B1 (ko) 2013-02-05
AU2010287421A1 (en) 2012-04-05
WO2011024973A1 (ja) 2011-03-03
ES2556336T3 (es) 2016-01-15
KR20130001337A (ko) 2013-01-03
US11452762B2 (en) 2022-09-27
CN102596216B (zh) 2016-04-20
CA2771215C (en) 2013-01-22
JPWO2011024973A1 (ja) 2013-01-31
MX2012002175A (es) 2012-06-27
US20130045921A1 (en) 2013-02-21
US9962429B2 (en) 2018-05-08
US20140243271A1 (en) 2014-08-28
DK2471546T3 (en) 2016-01-25
RU2502519C2 (ru) 2013-12-27
RU2012105046A (ru) 2013-10-10
EP2471546A1 (en) 2012-07-04
US20170007673A1 (en) 2017-01-12

Similar Documents

Publication Publication Date Title
HK1171682A1 (en) Therapeutic agent for rhinitis
GB0908957D0 (en) Therapeutic agents
IL214919A0 (en) Method for therapeutic use
AP3250A (en) Tablets for combination therapy
ZA201100904B (en) Therapeutic agent for migraine
HRP20171418T1 (hr) Terapeutsko sredstvo za poremećaje anksioznosti
EP2510949A4 (en) THERAPEUTICS FOR FIBROMYALGIA
EP2427183A4 (en) THERAPEUTIC COMPOUNDS
GB0900484D0 (en) Therapeutic agent
EP2496704A4 (en) THERAPEUTIC COMPOUNDS
GB0910493D0 (en) Therapeutic agents
EP2456309A4 (en) THERAPEUTIC COMPOUNDS
GB0906026D0 (en) Therapeutic compounds
GB0919819D0 (en) Therapeutic agents
GB0903949D0 (en) Therapeutic agents
GB0919829D0 (en) Therapeutic agents
GB0911965D0 (en) Therapeutic agents
GB0907971D0 (en) Therapeutic agents
GB0915586D0 (en) Therapeutic agents
GB0919821D0 (en) Therapeutic agents
GB0914533D0 (en) Therapeutic agents
GB0919825D0 (en) Therapeutic agents
GB0919820D0 (en) Therapeutic agents
GB0919824D0 (en) Therapeutic agents
GB0902450D0 (en) Therapeutic agents